X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs ELDER PHARMA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA ELDER PHARMA FULFORD INDIA/
ELDER PHARMA
 
P/E (TTM) x 398.8 -0.2 - View Chart
P/BV x 6.2 0.1 6,158.7% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 FULFORD INDIA   ELDER PHARMA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
ELDER PHARMA
Jun-14
FULFORD INDIA/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs942380 247.9%   
Low Rs450188 239.4%   
Sales per share (Unadj.) Rs691.4491.2 140.8%  
Earnings per share (Unadj.) Rs11.5-3.2 -360.2%  
Cash flow per share (Unadj.) Rs15.414.4 106.6%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.30-  
Book value per share (Unadj.) Rs380.0376.5 100.9%  
Shares outstanding (eoy) m3.9020.54 19.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.00.6 174.1%   
Avg P/E ratio x60.7-89.3 -68.0%  
P/CF ratio (eoy) x45.319.7 229.9%  
Price / Book Value ratio x1.80.8 242.8%  
Dividend payout %17.40-   
Avg Mkt Cap Rs m2,7145,833 46.5%   
No. of employees `0000.4NA-   
Total wages/salary Rs m5052,179 23.2%   
Avg. sales/employee Rs Th6,073.0NM-  
Avg. wages/employee Rs Th1,137.4NM-  
Avg. net profit/employee Rs Th100.7NM-  
INCOME DATA
Net Sales Rs m2,69610,089 26.7%  
Other income Rs m125257 48.9%   
Total revenues Rs m2,82210,346 27.3%   
Gross profit Rs m-46-792 5.9%  
Depreciation Rs m15361 4.2%   
Interest Rs m102,756 0.3%   
Profit before tax Rs m54-3,653 -1.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m10125 7.7%   
Profit after tax Rs m45-65 -68.4%  
Gross profit margin %-1.7-7.8 21.9%  
Effective tax rate %17.7-3.4 -516.0%   
Net profit margin %1.7-0.6 -255.9%  
BALANCE SHEET DATA
Current assets Rs m1,7389,240 18.8%   
Current liabilities Rs m5459,998 5.4%   
Net working cap to sales %44.3-7.5 -589.4%  
Current ratio x3.20.9 345.3%  
Inventory Days Days4846 104.7%  
Debtors Days Days460 7.2%  
Net fixed assets Rs m1210,124 0.1%   
Share capital Rs m39206 19.0%   
"Free" reserves Rs m1,4435,582 25.8%   
Net worth Rs m1,4827,734 19.2%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m2,07722,882 9.1%  
Interest coverage x6.7-0.3 -2,064.5%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.30.4 294.5%   
Return on assets %2.611.8 22.2%  
Return on equity %3.0-0.8 -356.9%  
Return on capital %4.322.3 19.3%  
Exports to sales %03.0 0.0%   
Imports to sales %24.50.4 5,723.5%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs m65943 1,529.7%   
Fx inflow Rs m17307 5.6%   
Fx outflow Rs m673125 537.2%   
Net fx Rs m-656181 -361.8%   
CASH FLOW
From Operations Rs m9011,754 0.8%  
From Investments Rs m105-561 -18.7%  
From Financial Activity Rs m-14-6,762 0.2%  
Net Cashflow Rs m1814,432 4.1%  

Share Holding

Indian Promoters % 0.0 39.6 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 7.5 50.7%  
FIIs % 0.1 16.8 0.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 36.1 58.7%  
Shareholders   4,783 16,479 29.0%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   PFIZER  GSK PHARMA  PANACEA BIOTECH  WYETH LTD  ABBOTT INDIA  

Compare FULFORD INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Macroeconomic Cues Guide the Markets This Week(Podcast)

Global markets remained in pressure this week. Pound fell sharply as risk of chaotic Brexit rose.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS